KWM
IFRX icon

Kingsview Wealth Management’s InflaRx IFRX Stock Holding History

Kingsview Wealth Management’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-71,870
Closed -$342K – 932
2021
Q4 		$342K Buy
+71,870
New +$289K 0.01% 680

Other funds holding IFRX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Kingsview Wealth Management's IFRX Position: Q1 2022 in Review

Kingsview Wealth Management sold out of InflaRx (IFRX) in Q1 2022, closing a stake of 71,870 shares — an estimated $342K sold.

Kingsview Wealth Management first reported a position in IFRX in Q4 2021 and held it in 1 quarter. The position peaked at $342K in Q4 2021. 32 funds tracked by Wall St. Rank hold IFRX as of Q1 2022.

  • Kingsview Wealth Management reported no remaining InflaRx position as of Q1 2022 after selling out during the quarter.
  • Kingsview Wealth Management sold 71,870 InflaRx shares in Q1 2022, an estimated $342K.
  • Kingsview Wealth Management first reported a position in InflaRx in Q4 2021 and held it in 1 quarter.
  • Kingsview Wealth Management's InflaRx position peaked at $342K in Q4 2021.
  • 32 funds tracked by Wall St. Rank held InflaRx as of Q1 2022.

Based on Kingsview Wealth Management's 13F filing for Q1 2022, filed 8 Feb 2024.